{"clinical_pharmacology":[""],"clinical_studies":[""],"effective_time":"20130520","id":"a02386ba-1097-42b7-b2ba-9161918f123f","inactive_ingredient":[""],"indications_and_usage":[""],"openfda":{},"package_label_principal_display_panel":["Micardis 20 mg - 30 Tablets NDC 64674-039-37 Micardis 20 mg 30 Tablets NDC 64674-039-37","Micardis 40 mg - 30 Tablets NDC 64674-040-37 Micardis 40 mg 30 Tablets NDC 64674-040-37","Micardis 80 mg - 30 Tablets NDC 64674-041-37 Micardis 80 mg 30 Tablets NDC 64674-041-37"],"precautions":[""],"set_id":"dcfc733c-d220-4a25-ab35-1ac3b610d5d8","spl_medguide":[""],"spl_product_data_elements":["Micardis telmisartan TELMISARTAN TELMISARTAN 50H; Micardis telmisartan TELMISARTAN TELMISARTAN 51H; Micardis telmisartan TELMISARTAN TELMISARTAN 52H;"],"use_in_specific_populations":[""],"version":"2","warnings":[""],"warnings_and_cautions":[""]}